Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects.
about
Clinical management of filovirus-infected patientsMolecular evidence of sexual transmission of Ebola virusAerosol Transmission of FilovirusesPresence and Persistence of Ebola or Marburg Virus in Patients and Survivors: A Rapid Systematic ReviewEffectiveness of Personal Protective Equipment for Healthcare Workers Caring for Patients with Filovirus Disease: A Rapid ReviewSystematic review of the literature on viral persistence and sexual transmission from recovered Ebola survivors: evidence and recommendationsTransmission of Ebola viruses: what we know and what we do not knowDiagnosis of Ebola Virus Disease: Past, Present, and FutureConfronting Ebola as a Sexually Transmitted InfectionClinical features and patient management of Lujo hemorrhagic feverEbola Viral Disease in West Africa: A Threat to Global Health, Economy and Political StabilityThe Baboon (Papio spp.) as a model of human Ebola virus infection.Von Willebrand factor is elevated in individuals infected with Sudan virus and is associated with adverse clinical outcomesPreparing a community hospital to manage work-related exposures to infectious agents in BioSafety level 3 and 4 laboratories.Time From Infection to Disease and Infectiousness for Ebola Virus Disease, a Systematic Review.Workplace Safety Concerns among Co-workers of Responder Returning from Ebola-Affected Country.Use of the Syrian hamster as a new model of ebola virus disease and other viral hemorrhagic fevers.Experimental Inoculation of Egyptian Fruit Bats (Rousettus aegyptiacus) with Ebola VirusPersistence of Ebola virus in various body fluids during convalescence: evidence and implications for disease transmission and control.Does this patient have Ebola virus disease?Clinical presentation and management of severe Ebola virus disease.Ebola virus disease, transmission risk to laboratory personnel, and pretransfusion testing.Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus.Perceptions of Ebola virus disease in Nigeria: Understanding the influence of imagination on health orientation.Ebola Virus Shedding and Transmission: Review of Current Evidence.Neurological Complications and Sequelae of Ebola Virus Disease.Rapid Visual Screening and Programmable Subtype Classification of Ebola Virus Biomarkers.Ebola virus disease: history, epidemiology and outbreaks.Understanding bleeding in ebola virus disease.Nonhuman primates as models for the discovery and development of ebolavirus therapeutics.Are we prepared for Ebola and other viral haemorrhagic fevers?Sexual and mother-to-child transmission of Ebola virus in the postconvalescent period.
P2860
Q22305518-668808B1-A18D-434E-92E8-924F7109E5B4Q23922091-06E8B1F1-E801-4115-AFAD-F455902DC203Q26745989-E90F7E30-54AB-4BB2-A5F3-C1678EA577D2Q26765404-CBA3FC05-6142-48FC-8F85-75FF041F64D3Q26785435-6A284A35-A406-46D3-8C96-07CC04FD0C41Q28076370-3EC2CBB1-8528-48AC-A0BD-E37C43C1346DQ28083565-20D09EC7-9E88-4255-A150-91E6A178BAF6Q28388534-A1A93222-D481-4B32-BEE0-D34CC688F846Q28393084-8638F1CD-970B-4D56-8CEC-0B69DD9F4696Q28544917-C316D555-B918-4D3B-A419-6BF26EF1F4B7Q30148821-BF29C011-98C6-4B11-B568-4E37BDD4E0D2Q33404644-4140B950-A47F-49A5-9A50-F0F36036C893Q34869398-148B6044-6EBF-4999-BA98-49E1AC469641Q35877436-351AF0F2-E143-4DE1-BBBF-EBDCB6174F4BQ36030522-6A58C988-5256-46CE-BA27-5190E8F16A55Q36212129-12DA96C1-B46D-4BED-AD43-5D57F94796AFQ36482804-E685EB55-D945-4ABF-9412-69F5FF359AFAQ36645486-A95065D2-AAF5-4F30-9DEA-728D542BD525Q36867542-EB781D97-FC17-4F32-8B0F-5EEC9F7810E6Q38245691-920624CC-9471-45B4-8BE9-4EB71837CD4CQ38264960-6C9C495B-893B-455D-BAB6-B9C58B461334Q38268877-B13D4919-4874-4EFC-905D-0BA520C6DCC3Q38877081-C8E84F71-C45E-4522-958B-5C0F275A9343Q38881001-DB4F5855-C3D1-4398-9183-5A5303A1715CQ38904658-2316AFE2-A67C-4FEF-9D96-519613C3270CQ39229493-60C39CCB-C1F2-4832-A38A-9A600DE4CE5AQ40076081-D73D7D59-5D52-4577-811A-43ADD7EB4990Q40159475-0128E8AD-54A6-41D3-8F47-CE000C1FBBCBQ40169485-6EB7F933-11B1-45D6-BF7B-9A0E4E1E00C8Q40332893-81659B57-6D26-4B66-95F1-D6BAE5E07F94Q44093723-8952355B-C70F-4FB7-A7AE-C4A1FC53FFC7Q44095339-FF64112F-448E-443C-8F2A-668D0A20AB1E
P2860
Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects.
@ast
Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects.
@en
Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects.
@nl
type
label
Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects.
@ast
Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects.
@en
Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects.
@nl
prefLabel
Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects.
@ast
Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects.
@en
Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects.
@nl
P2093
P1476
Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects.
@en
P2093
De La Rey IC
Kassianides C
Richards GA
Swanepoel R
P304
P356
10.1097/00003246-200001000-00041
P407
P577
2000-01-01T00:00:00Z